# Cisplatin Disposition and Kidney Injury

> **NCT03817970** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 72 (estimated)

## Conditions studied

- Nephrotoxicity

## Interventions

- **DRUG:** Granisetron
- **DRUG:** Ondansetron
- **DRUG:** Palonosetron

## Key facts

- **NCT ID:** NCT03817970
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-11-15
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-08-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03817970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03817970, "Cisplatin Disposition and Kidney Injury". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03817970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*